bioAffinity Technologies GAAP EPS of -$8.66, revenue of $6.2M
Source: SeekingAlpha
2026-03-13 15:15:54 ET
More on bioAffinity Technologies
Read the full article on Seeking Alpha
For further details see:
bioAffinity Technologies GAAP EPS of -$8.66, revenue of $6.2M
bioAffinity Technologies Inc.
NASDAQ: BIAF
BIAF Trading
17.85% G/L:
$2.5809 Last:
2,876,263 Volume:
$2.42 Open:
BIAF Latest News
March 17, 2026 09:44:58 am
Small Caps Surge on Breakouts, Biotech Validation, and "Real-World" Tech Adoption
March 17, 2026 08:30:59 am
Case Study Highlights How CyPath Lung Helps Patients Avoid Invasive Procedures
BIAF Stock Data
$4,543,696
4,349,802
N/A
3
N/A
Medical Diagnostics & Screening
Healthcare
US
San Antonio
